Evidence for dual receptor-binding sites in Clostridium difficile toxin A

FEBS Letters

Volumn 590, Issue 24, 2016, Pages 4550-4563

  Lambert, Gregory S ^a   Baldwin, Michael R ^a  

^a University of Missouri   (United States)

Author keywords

Clostridium difficile; receptor binding domain; TcdA

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; BACTERIAL PROTEIN; BACTERIAL TOXIN; ENTEROTOXIN; OLIGOPEPTIDE; PROTEIN BINDING; RECOMBINANT PROTEIN; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE; TOXB PROTEIN, CLOSTRIDIUM DIFFICILE;

BINDING SITE; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; ENDOSOME; INTERNALIZATION; INTESTINE CELL; LETTER; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR BINDING; CELL MEMBRANE; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; HT-29 CELL LINE; HUMAN; METABOLISM; PATHOGENICITY; PEPTOCLOSTRIDIUM DIFFICILE; TRANSPORT AT THE CELLULAR LEVEL;

BACTERIAL PROTEINS; BACTERIAL TOXINS; BINDING SITES; BIOLOGICAL TRANSPORT; CELL MEMBRANE; CELL SURVIVAL; CLOSTRIDIUM DIFFICILE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTEROTOXINS; ESCHERICHIA COLI; GENE EXPRESSION; HT29 CELLS; HUMANS; OLIGOPEPTIDES; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECOMBINANT PROTEINS;

EID: 85006162898     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1002/1873-3468.12487     Document Type: Article

References (52)

1. Kelly CP and LaMont JT (2008) Clostridium difficile – more difficult than ever. N Engl J Med 359, 1932–1940.
2. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M et al. (2005) A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353, 2442–2449.
3. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, Johnson S and Gerding DN (2005) An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353, 2433–2441.
4. Voth DE and Ballard JD (2005) Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 18, 247–263.
5. Aktories K (2011) Bacterial protein toxins that modify host regulatory GTPases. Nat Rev Microbiol 9, 487–498.
6. Busch C and Aktories K (2000) Microbial toxins and the glycosylation of rho family GTPases. Curr Opin Struct Biol 10, 528–535.
7. Just I, Wilm M, Selzer J, Rex G, von Eichel-Streiber C, Mann M and Aktories K (1995) The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem 270, 13932–13936.
8. Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M and Aktories K (1995) Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375, 500–503.
9. Just I and Gerhard R (2004) Large clostridial cytotoxins. Rev Physiol Biochem Pharmacol 152, 23–47.
10. von Eichel-Streiber C, Boquet P, Sauerborn M and Thelestam M (1996) Large clostridial cytotoxins – a family of glycosyltransferases modifying small GTP-binding proteins. Trends Microbiol 4, 375–382.
11. Schirmer J and Aktories K (2004) Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins. Biochim Biophys Acta 1673, 66–74.
12. Hofmann F, Busch C, Prepens U, Just I and Aktories K (1997) Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin. J Biol Chem 272, 11074–11078.
13. Genth H, Aktories K and Just I (1999) Monoglucosylation of RhoA at threonine 37 blocks cytosol-membrane cycling. J Biol Chem 274, 29050–29056.
14. Busch C, Hofmann F, Selzer J, Munro S, Jeckel D and Aktories K (1998) A common motif of eukaryotic glycosyltransferases is essential for the enzyme activity of large clostridial cytotoxins. J Biol Chem 273, 19566–19572.
15. Jank T, Giesemann T and Aktories K (2007) Clostridium difficile glucosyltransferase toxin B-essential amino acids for substrate binding. J Biol Chem 282, 35222–35231.
16. Reinert DJ, Jank T, Aktories K and Schulz GE (2005) Structural basis for the function of Clostridium difficile toxin B. J Mol Biol 351, 973–981.
17. Reineke J, Tenzer S, Rupnik M, Koschinski A, Hasselmayer O, Schrattenholz A, Schild H and von Eichel-Streiber C (2007) Autocatalytic cleavage of Clostridium difficile toxin B. Nature 446, 415–419.
18. Egerer M, Giesemann T, Jank T, Satchell KJ and Aktories K (2007) Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity. J Biol Chem 282, 25314–25321.
19. Pruitt RN, Chagot B, Cover M, Chazin WJ, Spiller B and Lacy DB (2009) Structure-function analysis of inositol hexakisphosphate-induced autoprocessing in Clostridium difficile toxin A. J Biol Chem 284, 21934–21940.
20. Genisyuerek S, Papatheodorou P, Guttenberg G, Schubert R, Benz R and Aktories K (2011) Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B. Mol Microbiol 79, 1643–1654.
21. Egerer M, Giesemann T, Herrmann C and Aktories K (2009) Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate. J Biol Chem 284, 3389–3395.
22. Barth H, Pfeifer G, Hofmann F, Maier E, Benz R and Aktories K (2001) Low pH-induced formation of ion channels by Clostridium difficile toxin B in target cells. J Biol Chem 276, 10670–10676.
23. Qa'Dan M, Spyres LM and Ballard JD (2000) pH-induced conformational changes in Clostridium difficile toxin B. Infect Immun 68, 2470–2474.
24. Giesemann T, Jank T, Gerhard R, Maier E, Just I, Benz R and Aktories K (2006) Cholesterol-dependent pore formation of Clostridium difficile toxin A. J Biol Chem 281, 10808–10815.
25. Pfeifer G, Schirmer J, Leemhuis J, Busch C, Meyer DK, Aktories K and Barth H (2003) Cellular uptake of Clostridium difficile toxin B. Translocation of the N-terminal catalytic domain into the cytosol of eukaryotic cells. J Biol Chem 278, 44535–44541.
26. Pruitt RN, Chambers MG, Ng KK, Ohi MD and Lacy DB (2010) Structural organization of the functional domains of Clostridium difficile toxins A and B. Proc Natl Acad Sci USA 107, 13467–13472.
27. Jank T and Aktories K (2008) Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol 16, 222–229.
28. von Eichel-Streiber C and Sauerborn M (1990) Clostridium difficile toxin A carries a C-terminal repetitive structure homologous to the carbohydrate binding region of streptococcal glycosyltransferases. Gene 96, 107–113.
29. Ho JG, Greco A, Rupnik M and Ng KK (2005) Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A. Proc Natl Acad Sci USA 102, 18373–18378.
30. Greco A, Ho JG, Lin SJ, Palcic MM, Rupnik M and Ng KK (2006) Carbohydrate recognition by Clostridium difficile toxin A. Nat Struct Mol Biol 13, 460–461.
31. Albesa-Jove D, Bertrand T, Carpenter EP, Swain GV, Lim J, Zhang J, Haire LF, Vasisht N, Braun V, Lange A et al. (2010) Four distinct structural domains in Clostridium difficile toxin B visualized using SAXS. J Mol Biol 396, 1260–1270.
32. Krivan HC, Clark GF, Smith DF and Wilkins TD (1986) Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc. Infect Immun 53, 573–581.
33. Na X, Kim H, Moyer MP, Pothoulakis C and LaMont JT (2008) gp96 is a human colonocyte plasma membrane binding protein for Clostridium difficile toxin A. Infect Immun 76, 2862–2871.
34. Pothoulakis C, Gilbert RJ, Cladaras C, Castagliuolo I, Semenza G, Hitti Y, Montcrief JS, Linevsky J, Kelly CP, Nikulasson S et al. (1996) Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A. J Clin Invest 98, 641–649.
35. von Eichel-Streiber C, Laufenberg-Feldmann R, Sartingen S, Schulze J and Sauerborn M (1992) Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol Gen Genet 233, 260–268.
36. Dove CH, Wang SZ, Price SB, Phelps CJ, Lyerly DM, Wilkins TD and Johnson JL (1990) Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun 58, 480–488.
37. Olling A, Goy S, Hoffmann F, Tatge H, Just I and Gerhard R (2011) The repetitive oligopeptide sequences modulate cytopathic potency but are not crucial for cellular uptake of Clostridium difficile toxin A. PLoS ONE 6, e17623.
38. Gerhard R, Frenzel E, Goy S and Olling A (2013) Cellular uptake of Clostridium difficile TcdA and truncated TcdA lacking the receptor binding domain. J Med Microbiol 62 (Pt 9), 1414–1422.
39. Amimoto K, Noro T, Oishi E and Shimizu M (2007) A novel toxin homologous to large clostridial cytotoxins found in culture supernatant of Clostridium perfringens type C. Microbiology 153 (Pt 9), 1198–1206.
40. Guttenberg G, Hornei S, Jank T, Schwan C, Lu W, Einsle O, Papatheodorou P and Aktories K (2012) Molecular characteristics of Clostridium perfringens TpeL toxin and consequences of mono-O-GlcNAcylation of Ras in living cells. J Biol Chem 287, 24929–24940.
41. Schorch B, Song S, van Diemen FR, Bock HH, May P, Herz J, Brummelkamp TR, Papatheodorou P and Aktories K (2014) LRP1 is a receptor for Clostridium perfringens TpeL toxin indicating a two-receptor model of clostridial glycosylating toxins. Proc Natl Acad Sci USA 111, 6431–6436.
42. LaFrance ME, Farrow MA, Chandrasekaran R, Sheng J, Rubin DH and Lacy DB (2015) Identification of an epithelial cell receptor responsible for Clostridium difficile TcdB-induced cytotoxicity. Proc Natl Acad Sci U S A 112, 7073–7078.
43. Tao L, Zhang J, Meraner P, Tovaglieri A, Wu X, Gerhard R, Zhang X, Stallcup WB, Miao J, He X et al. (2016) Frizzled proteins are colonic epithelial receptors for C. difficile toxin B. Nature 538, 350–355.
44. Yuan P, Zhang H, Cai C, Zhu S, Zhou Y, Yang X, He R, Li C, Guo S, Li S et al. (2015) Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B. Cell Res 25, 157–168.
45. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A and Minton NP (2010) The role of toxin A and toxin B in Clostridium difficile infection. Nature 467, 711–713.
46. Burger S, Tatge H, Hofmann F, Genth H, Just I and Gerhard R (2003) Expression of recombinant Clostridium difficile toxin A using the Bacillus megaterium system. Biochem Biophys Res Commun 307, 584–588.
47. Yang G, Zhou B, Wang J, He X, Sun X, Nie W, Tzipori S and Feng H (2008) Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium. BMC Microbiol 8, 192.
48. Manse JS and Baldwin MR (2015) Binding and entry of Clostridium difficile toxin B is mediated by multiple domains. FEBS Lett 589 (Pt B), 3945–51.
49. Sreerama N and Woody RW (2004) On the analysis of membrane protein circular dichroism spectra. Protein Sci 13, 100–112.
50. Chumbler NM, Rutherford SA, Zhang Z, Farrow MA, Lisher JP, Farquhar E, Giedroc DP, Spiller BW, Melnyk RA and Lacy DB (2016) Crystal structure of Clostridium difficile toxin A. Nat Microbiol 1, 15002.
51. Zhang Z, Park M, Tam J, Auger A, Beilhartz GL, Lacy DB and Melnyk RA (2014) Translocation domain mutations affecting cellular toxicity identify the Clostridium difficile toxin B pore. Proc Natl Acad Sci U S A 111, 3721–3726.
52. Olling A, Huls C, Goy S, Muller M, Krooss S, Rudolf I, Tatge H and Gerhard R (2014) The combined repetitive oligopeptides of Clostridium difficile toxin A counteract premature cleavage of the glucosyl-transferase domain by stabilizing protein conformation. Toxins (Basel) 6, 2162–2176.